Toll Free: 1-888-928-9744

Global Imatinib Drugs Sales Market Report 2017

Published: Aug 8, 2017 | Pages: 100 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the global Imatinib Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Imatinib Drugs for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Imatinib Drugs market competition by top manufacturers/players, with Imatinib Drugs sales volume, Price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Apotex Inc.
    Novartis
    Sanofi S.A.
    Cipla Inc.
    Mylan Pharms Inc.
    Glenmark Pharmaceuticals Ltd.
    Sun Pharmaceuticals
    Actavis Generics
    Dr. Reddy's Laboratories
    Teva Pharmaceutical Industries Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Capsules
    Tablets
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Imatinib Drugs for each application, including
    Hospitals
    Drug Stores
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Global Imatinib Drugs Sales Market Report 2017
1 Imatinib Drugs Market Overview
    1.1 Product Overview and Scope of Imatinib Drugs
    1.2 Classification of Imatinib Drugs by Product Category
        1.2.1 Global Imatinib Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Imatinib Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Capsules
        1.2.4 Tablets
    1.3 Global Imatinib Drugs Market by Application/End Users
        1.3.1 Global Imatinib Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Drug Stores
        1.3.4 Other
    1.4 Global Imatinib Drugs Market by Region
        1.4.1 Global Imatinib Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Imatinib Drugs Status and Prospect (2012-2022)
        1.4.3 China Imatinib Drugs Status and Prospect (2012-2022)
        1.4.4 Europe Imatinib Drugs Status and Prospect (2012-2022)
        1.4.5 Japan Imatinib Drugs Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Imatinib Drugs Status and Prospect (2012-2022)
        1.4.7 India Imatinib Drugs Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Imatinib Drugs (2012-2022)
        1.5.1 Global Imatinib Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Global Imatinib Drugs Revenue and Growth Rate (2012-2022)

2 Global Imatinib Drugs Competition by Players/Suppliers, Type and Application
     2.1 Global Imatinib Drugs Market Competition by Players/Suppliers
        2.1.1 Global Imatinib Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Imatinib Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Imatinib Drugs (Volume and Value) by Type
        2.2.1 Global Imatinib Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Global Imatinib Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Global Imatinib Drugs (Volume and Value) by Region
        2.3.1 Global Imatinib Drugs Sales and Market Share by Region (2012-2017)
        2.3.2 Global Imatinib Drugs Revenue and Market Share by Region (2012-2017)
    2.4 Global Imatinib Drugs (Volume) by Application

3 United States Imatinib Drugs (Volume, Value and Sales Price)
    3.1 United States Imatinib Drugs Sales and Value (2012-2017)
        3.1.1 United States Imatinib Drugs Sales and Growth Rate (2012-2017)
        3.1.2 United States Imatinib Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 United States Imatinib Drugs Sales Price Trend (2012-2017)
    3.2 United States Imatinib Drugs Sales Volume and Market Share by Players
    3.3 United States Imatinib Drugs Sales Volume and Market Share by Type
    3.4 United States Imatinib Drugs Sales Volume and Market Share by Application

4 China Imatinib Drugs (Volume, Value and Sales Price)
    4.1 China Imatinib Drugs Sales and Value (2012-2017)
        4.1.1 China Imatinib Drugs Sales and Growth Rate (2012-2017)
        4.1.2 China Imatinib Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 China Imatinib Drugs Sales Price Trend (2012-2017)
    4.2 China Imatinib Drugs Sales Volume and Market Share by Players
    4.3 China Imatinib Drugs Sales Volume and Market Share by Type
    4.4 China Imatinib Drugs Sales Volume and Market Share by Application

5 Europe Imatinib Drugs (Volume, Value and Sales Price)
    5.1 Europe Imatinib Drugs Sales and Value (2012-2017)
        5.1.1 Europe Imatinib Drugs Sales and Growth Rate (2012-2017)
        5.1.2 Europe Imatinib Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Imatinib Drugs Sales Price Trend (2012-2017)
    5.2 Europe Imatinib Drugs Sales Volume and Market Share by Players
    5.3 Europe Imatinib Drugs Sales Volume and Market Share by Type
    5.4 Europe Imatinib Drugs Sales Volume and Market Share by Application

6 Japan Imatinib Drugs (Volume, Value and Sales Price)
    6.1 Japan Imatinib Drugs Sales and Value (2012-2017)
        6.1.1 Japan Imatinib Drugs Sales and Growth Rate (2012-2017)
        6.1.2 Japan Imatinib Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Imatinib Drugs Sales Price Trend (2012-2017)
    6.2 Japan Imatinib Drugs Sales Volume and Market Share by Players
    6.3 Japan Imatinib Drugs Sales Volume and Market Share by Type
    6.4 Japan Imatinib Drugs Sales Volume and Market Share by Application

7 Southeast Asia Imatinib Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Imatinib Drugs Sales and Value (2012-2017)
        7.1.1 Southeast Asia Imatinib Drugs Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Imatinib Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Imatinib Drugs Sales Price Trend (2012-2017)
    7.2 Southeast Asia Imatinib Drugs Sales Volume and Market Share by Players
    7.3 Southeast Asia Imatinib Drugs Sales Volume and Market Share by Type
    7.4 Southeast Asia Imatinib Drugs Sales Volume and Market Share by Application

8 India Imatinib Drugs (Volume, Value and Sales Price)
    8.1 India Imatinib Drugs Sales and Value (2012-2017)
        8.1.1 India Imatinib Drugs Sales and Growth Rate (2012-2017)
        8.1.2 India Imatinib Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 India Imatinib Drugs Sales Price Trend (2012-2017)
    8.2 India Imatinib Drugs Sales Volume and Market Share by Players
    8.3 India Imatinib Drugs Sales Volume and Market Share by Type
    8.4 India Imatinib Drugs Sales Volume and Market Share by Application

9 Global Imatinib Drugs Players/Suppliers Profiles and Sales Data
    9.1 Apotex Inc.
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Imatinib Drugs Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Apotex Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Novartis
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Imatinib Drugs Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Novartis Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Sanofi S.A.
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Imatinib Drugs Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Sanofi S.A. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Cipla Inc.
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Imatinib Drugs Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Cipla Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Mylan Pharms Inc.
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Imatinib Drugs Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Glenmark Pharmaceuticals Ltd.
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Imatinib Drugs Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Sun Pharmaceuticals
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Imatinib Drugs Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Sun Pharmaceuticals Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Actavis Generics
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Imatinib Drugs Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Actavis Generics Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Dr. Reddy's Laboratories
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Imatinib Drugs Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Teva Pharmaceutical Industries Ltd.
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Imatinib Drugs Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview

10 Imatinib Drugs Maufacturing Cost Analysis
    10.1 Imatinib Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Imatinib Drugs
    10.3 Manufacturing Process Analysis of Imatinib Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Imatinib Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Imatinib Drugs Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Imatinib Drugs Market Forecast (2017-2022)
    14.1 Global Imatinib Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Imatinib Drugs Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Imatinib Drugs Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Imatinib Drugs Price and Trend Forecast (2017-2022)
    14.2 Global Imatinib Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Imatinib Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Imatinib Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Imatinib Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Imatinib Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Imatinib Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Imatinib Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Imatinib Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Imatinib Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Imatinib Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Imatinib Drugs Sales Forecast by Type (2017-2022)
       14.3.2 Global Imatinib Drugs Revenue Forecast by Type (2017-2022)
       14.3.3 Global Imatinib Drugs Price Forecast by Type (2017-2022)
    14.4 Global Imatinib Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer


List of Tables and FiguresList of Tables and Figures

    Figure Product Picture of Imatinib Drugs
    Figure Global Imatinib Drugs Sales Volume Comparison (MT) by Type (2012-2022)
    Figure Global Imatinib Drugs Sales Volume Market Share by Type (Product Category) in 2016
    Figure Capsules Product Picture
    Figure Tablets Product Picture
    Figure Global Imatinib Drugs Sales Comparison (MT) by Application (2012-2022)
    Figure Global Sales Market Share of Imatinib Drugs by Application in 2016
    Figure Hospitals Examples
    Table Key Downstream Customer in Hospitals
    Figure Drug Stores Examples
    Table Key Downstream Customer in Drug Stores
    Figure Other Examples
    Table Key Downstream Customer in Other
    Figure Global Imatinib Drugs Market Size (Million USD) by Regions (2012-2022)
    Figure United States Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure China Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Japan Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southeast Asia Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure India Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Global Imatinib Drugs Sales Volume (MT) and Growth Rate (2012-2022)
    Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Global Market Major Players Imatinib Drugs Sales Volume (MT) (2012-2017)
    Table Global Imatinib Drugs Sales (MT) of Key Players/Suppliers (2012-2017)
    Table Global Imatinib Drugs Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 Imatinib Drugs Sales Share by Players/Suppliers
    Figure 2017 Imatinib Drugs Sales Share by Players/Suppliers
    Figure Global Imatinib Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table Global Imatinib Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table Global Imatinib Drugs Revenue Share by Players/Suppliers (2012-2017)
    Table 2016 Global Imatinib Drugs Revenue Share by Players
    Table 2017 Global Imatinib Drugs Revenue Share by Players
    Table Global Imatinib Drugs Sales (MT) and Market Share by Type (2012-2017)
    Table Global Imatinib Drugs Sales Share (MT) by Type (2012-2017)
    Figure Sales Market Share of Imatinib Drugs by Type (2012-2017)
    Figure Global Imatinib Drugs Sales Growth Rate by Type (2012-2017)
    Table Global Imatinib Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
    Table Global Imatinib Drugs Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Imatinib Drugs by Type (2012-2017)
    Figure Global Imatinib Drugs Revenue Growth Rate by Type (2012-2017)
    Table Global Imatinib Drugs Sales Volume (MT) and Market Share by Region (2012-2017)
    Table Global Imatinib Drugs Sales Share by Region (2012-2017)
    Figure Sales Market Share of Imatinib Drugs by Region (2012-2017)
    Figure Global Imatinib Drugs Sales Growth Rate by Region in 2016
    Table Global Imatinib Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
    Table Global Imatinib Drugs Revenue Share (%) by Region (2012-2017)
    Figure Revenue Market Share of Imatinib Drugs by Region (2012-2017)
    Figure Global Imatinib Drugs Revenue Growth Rate by Region in 2016
    Table Global Imatinib Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
    Table Global Imatinib Drugs Revenue Share (%) by Region (2012-2017)
    Figure Revenue Market Share of Imatinib Drugs by Region (2012-2017)
    Figure Global Imatinib Drugs Revenue Market Share by Region in 2016
    Table Global Imatinib Drugs Sales Volume (MT) and Market Share by Application (2012-2017)
    Table Global Imatinib Drugs Sales Share (%) by Application (2012-2017)
    Figure Sales Market Share of Imatinib Drugs by Application (2012-2017)
    Figure Global Imatinib Drugs Sales Market Share by Application (2012-2017)
    Figure United States Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure United States Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
    Table United States Imatinib Drugs Sales Volume (MT) by Players (2012-2017)
    Table United States Imatinib Drugs Sales Volume Market Share by Players (2012-2017)
    Figure United States Imatinib Drugs Sales Volume Market Share by Players in 2016
    Table United States Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
    Table United States Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
    Figure United States Imatinib Drugs Sales Volume Market Share by Type in 2016
    Table United States Imatinib Drugs Sales Volume (MT) by Application (2012-2017)
    Table United States Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
    Figure United States Imatinib Drugs Sales Volume Market Share by Application in 2016
    Figure China Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure China Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure China Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
    Table China Imatinib Drugs Sales Volume (MT) by Players (2012-2017)
    Table China Imatinib Drugs Sales Volume Market Share by Players (2012-2017)
    Figure China Imatinib Drugs Sales Volume Market Share by Players in 2016
    Table China Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
    Table China Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
    Figure China Imatinib Drugs Sales Volume Market Share by Type in 2016
    Table China Imatinib Drugs Sales Volume (MT) by Application (2012-2017)
    Table China Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
    Figure China Imatinib Drugs Sales Volume Market Share by Application in 2016
    Figure Europe Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Europe Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Europe Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
    Table Europe Imatinib Drugs Sales Volume (MT) by Players (2012-2017)
    Table Europe Imatinib Drugs Sales Volume Market Share by Players (2012-2017)
    Figure Europe Imatinib Drugs Sales Volume Market Share by Players in 2016
    Table Europe Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
    Table Europe Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
    Figure Europe Imatinib Drugs Sales Volume Market Share by Type in 2016
    Table Europe Imatinib Drugs Sales Volume (MT) by Application (2012-2017)
    Table Europe Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
    Figure Europe Imatinib Drugs Sales Volume Market Share by Application in 2016
    Figure Japan Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Japan Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Japan Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
    Table Japan Imatinib Drugs Sales Volume (MT) by Players (2012-2017)
    Table Japan Imatinib Drugs Sales Volume Market Share by Players (2012-2017)
    Figure Japan Imatinib Drugs Sales Volume Market Share by Players in 2016
    Table Japan Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
    Table Japan Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
    Figure Japan Imatinib Drugs Sales Volume Market Share by Type in 2016
    Table Japan Imatinib Drugs Sales Volume (MT) by Application (2012-2017)
    Table Japan Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
    Figure Japan Imatinib Drugs Sales Volume Market Share by Application in 2016
    Figure Southeast Asia Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Southeast Asia Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Southeast Asia Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
    Table Southeast Asia Imatinib Drugs Sales Volume (MT) by Players (2012-2017)
    Table Southeast Asia Imatinib Drugs Sales Volume Market Share by Players (2012-2017)
    Figure Southeast Asia Imatinib Drugs Sales Volume Market Share by Players in 2016
    Table Southeast Asia Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
    Table Southeast Asia Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
    Figure Southeast Asia Imatinib Drugs Sales Volume Market Share by Type in 2016
    Table Southeast Asia Imatinib Drugs Sales Volume (MT) by Application (2012-2017)
    Table Southeast Asia Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
    Figure Southeast Asia Imatinib Drugs Sales Volume Market Share by Application in 2016
    Figure India Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure India Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure India Imatinib Drugs Sales Price (USD/Kg) Trend (2012-2017)
    Table India Imatinib Drugs Sales Volume (MT) by Players (2012-2017)
    Table India Imatinib Drugs Sales Volume Market Share by Players (2012-2017)
    Figure India Imatinib Drugs Sales Volume Market Share by Players in 2016
    Table India Imatinib Drugs Sales Volume (MT) by Type (2012-2017)
    Table India Imatinib Drugs Sales Volume Market Share by Type (2012-2017)
    Figure India Imatinib Drugs Sales Volume Market Share by Type in 2016
    Table India Imatinib Drugs Sales Volume (MT) by Application (2012-2017)
    Table India Imatinib Drugs Sales Volume Market Share by Application (2012-2017)
    Figure India Imatinib Drugs Sales Volume Market Share by Application in 2016
    Table Apotex Inc. Basic Information List
    Table Apotex Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Apotex Inc. Imatinib Drugs Sales Growth Rate (2012-2017)
    Figure Apotex Inc. Imatinib Drugs Sales Global Market Share (2012-2017
    Figure Apotex Inc. Imatinib Drugs Revenue Global Market Share (2012-2017)
    Table Novartis Basic Information List
    Table Novartis Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Novartis Imatinib Drugs Sales Growth Rate (2012-2017)
    Figure Novartis Imatinib Drugs Sales Global Market Share (2012-2017
    Figure Novartis Imatinib Drugs Revenue Global Market Share (2012-2017)
    Table Sanofi S.A. Basic Information List
    Table Sanofi S.A. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Sanofi S.A. Imatinib Drugs Sales Growth Rate (2012-2017)
    Figure Sanofi S.A. Imatinib Drugs Sales Global Market Share (2012-2017
    Figure Sanofi S.A. Imatinib Drugs Revenue Global Market Share (2012-2017)
    Table Cipla Inc. Basic Information List
    Table Cipla Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Cipla Inc. Imatinib Drugs Sales Growth Rate (2012-2017)
    Figure Cipla Inc. Imatinib Drugs Sales Global Market Share (2012-2017
    Figure Cipla Inc. Imatinib Drugs Revenue Global Market Share (2012-2017)
    Table Mylan Pharms Inc. Basic Information List
    Table Mylan Pharms Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Mylan Pharms Inc. Imatinib Drugs Sales Growth Rate (2012-2017)
    Figure Mylan Pharms Inc. Imatinib Drugs Sales Global Market Share (2012-2017
    Figure Mylan Pharms Inc. Imatinib Drugs Revenue Global Market Share (2012-2017)
    Table Glenmark Pharmaceuticals Ltd. Basic Information List
    Table Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Growth Rate (2012-2017)
    Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Global Market Share (2012-2017
    Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Revenue Global Market Share (2012-2017)
    Table Sun Pharmaceuticals Basic Information List
    Table Sun Pharmaceuticals Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Sun Pharmaceuticals Imatinib Drugs Sales Growth Rate (2012-2017)
    Figure Sun Pharmaceuticals Imatinib Drugs Sales Global Market Share (2012-2017
    Figure Sun Pharmaceuticals Imatinib Drugs Revenue Global Market Share (2012-2017)
    Table Actavis Generics Basic Information List
    Table Actavis Generics Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Actavis Generics Imatinib Drugs Sales Growth Rate (2012-2017)
    Figure Actavis Generics Imatinib Drugs Sales Global Market Share (2012-2017
    Figure Actavis Generics Imatinib Drugs Revenue Global Market Share (2012-2017)
    Table Dr. Reddy's Laboratories Basic Information List
    Table Dr. Reddy's Laboratories Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Dr. Reddy's Laboratories Imatinib Drugs Sales Growth Rate (2012-2017)
    Figure Dr. Reddy's Laboratories Imatinib Drugs Sales Global Market Share (2012-2017
    Figure Dr. Reddy's Laboratories Imatinib Drugs Revenue Global Market Share (2012-2017)
    Table Teva Pharmaceutical Industries Ltd. Basic Information List
    Table Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Growth Rate (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Global Market Share (2012-2017
    Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Revenue Global Market Share (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Imatinib Drugs
    Figure Manufacturing Process Analysis of Imatinib Drugs
    Figure Imatinib Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Imatinib Drugs Major Players in 2016
    Table Major Buyers of Imatinib Drugs
    Table Distributors/Traders List
    Figure Global Imatinib Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
    Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Imatinib Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
    Table Global Imatinib Drugs Sales Volume (MT) Forecast by Regions (2017-2022)
    Figure Global Imatinib Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
    Figure Global Imatinib Drugs Sales Volume Market Share Forecast by Regions in 2022
    Table Global Imatinib Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
    Figure Global Imatinib Drugs Revenue Market Share Forecast by Regions (2017-2022)
    Figure Global Imatinib Drugs Revenue Market Share Forecast by Regions in 2022
    Figure United States Imatinib Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
    Figure United States Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure China Imatinib Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
    Figure China Imatinib Drugs Revenue and Growth Rate Forecast (2017-2022)
    Figure Europe Imatinib Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
    Figure Europe Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Japan Imatinib Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
    Figure Japan Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Imatinib Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure India Imatinib Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
    Figure India Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Global Imatinib Drugs Sales (MT) Forecast by Type (2017-2022)
    Figure Global Imatinib Drugs Sales Volume Market Share Forecast by Type (2017-2022)
    Table Global Imatinib Drugs Revenue (Million USD) Forecast by Type (2017-2022)
    Figure Global Imatinib Drugs Revenue Market Share Forecast by Type (2017-2022)
    Table Global Imatinib Drugs Price (USD/Kg) Forecast by Type (2017-2022)
    Table Global Imatinib Drugs Sales (MT) Forecast by Application (2017-2022)
    Figure Global Imatinib Drugs Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...

Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. Evolv

Read More...

Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commerc

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...
Choose License Type
Single User - US $4000
Multi User - US $8000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify